2026-11-19 ペンシルベニア州立大学(Penn State)

fig.説明
<関連情報>
- https://www.psu.edu/news/research/story/light-activated-nanoparticles-may-help-treat-head-and-neck-cancer
- https://onlinelibrary.wiley.com/doi/10.1002/jbm.a.70142
頭頸部がん抑制に向けた、光活性化によるマイクロRNA-20a送達システムの開発
Photo-Activated microRNA 20a Delivery via Core-Shell-Shell Nanoparticles for the Suppression of Head and Neck Cancer
Angelica M. Helton, Tyus J. Yeingst, Lindsay P. Stone, Dylan P. Kearse, Neerav Goyal, Douglas B. Stairs, Daniel J. Hayes
Journal of Biomedical Materials Research Part A Volume 114, Issue 9、論文番号 e70142 公開日:2026年9月4日
DOI:10.1002/jbm.a.70142

Graphical depictions of the photo-responsive CSS nanoparticle delivery system. (A) Wavelength of nanoparticle photo-responsivity based on composition formed an electron cloud through localized surface plasmon resonance. (B) CSS nanoparticle functionalized with the miRNA mimic via the Diels–Alder linker. Upon activation with near-infrared light (irradiation), the linker undergoes the retrograde Diels–Alder reaction and releases the miRNA therapeutic. Figure created in BioRender and Abobe Illustrator.Creative Commons CC BY 4.0
頭頸部扁平上皮がんでは、手術や放射線・化学療法によって腫瘍を制御できても、発声・嚥下・呼吸などに深刻な機能障害が残る場合がある。本研究は、治療薬を腫瘍部位で選択的に放出するため、金・銀・金からなるコア・シェル・シェル(CSS)型プラズモニックナノ粒子を開発した。粒子表面には、温度応答性のフラン系ディールス・アルダー結合を介して、アポトーシス関連遺伝子の発現を調節するmiRNA模倣体miR-20a-5pを結合させた。この粒子は近赤外領域の波長849 nmに光学応答のピークを持ち、850 nmの光を照射すると局所的な光熱反応によって結合が切断され、miRNAを放出する。培養した頭頸部がん細胞では、光照射下で50 nMのmiRNAを送達すると細胞生存率が約60%低下し、複数のアポトーシス関連標的遺伝子の発現抑制が確認された。さらに、ヒト由来がん細胞を移植したマウスでは、単回投与後に光照射した腫瘍の体積が48時間以内に約95%減少した。光によって薬剤放出の場所と時間を制御できる点が特徴であり、正常組織への影響を抑えながら腫瘍を縮小させる治療技術への応用が期待される。ただし、現段階では細胞および動物モデルでの前臨床研究であり、人での安全性・有効性は未確認である。
Conventional treatments for head and neck squamous cell carcinoma can cause substantial functional impairments, including difficulties with speaking, swallowing, and breathing. This study developed plasmonic gold-silver-gold core-shell-shell (CSS) nanoparticles to enable spatially and temporally controlled delivery of a miR-20a-5p mimic. The nanoparticles were functionalized with the miRNA using a thermo-responsive furan-based Diels–Alder linker. Their optical response peaked at 849 nm, allowing near-infrared irradiation at 850 nm to trigger a photothermal reaction and release the miRNA. In cultured head and neck cancer cells, photo-activated delivery of 50 nM miR-20a-5p reduced cell survival by approximately 60% and suppressed multiple target genes involved in apoptosis signaling. In mouse xenograft models, a single administration of 100 picomoles of the nanoparticle-delivered miRNA, followed by light activation, reduced the volume of illuminated FaDu tumors by approximately 95% within 48 hours. The system offers a potential strategy for localized cancer treatment by controlling where and when therapeutic RNA is released, potentially limiting effects on surrounding healthy tissues. However, the findings are based on cell culture and animal experiments; clinical safety and efficacy in humans remain to be established.
原著論文:Wiley Online Library

